Alvir JM - Search Results

1

Reliability, validity, and responsiveness of the daily sleep interference scale among diabetic peripheral neuropathy and postherpetic neuralgia patients.

Vernon MK, Brandenburg NA, Alvir JM, Griesing T, Revicki DA. Vernon MK, et al. Among authors: alvir jm. J Pain Symptom Manage. 2008 Jul;36(1):54-68. doi: 10.1016/j.jpainsymman.2007.09.016. Epub 2008 Apr 14. J Pain Symptom Manage. 2008. PMID: 18411009 Free article.

2

How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?

Hoffman DL, Sadosky A, Dukes EM, Alvir J. Hoffman DL, et al. Pain. 2010 May;149(2):194-201. doi: 10.1016/j.pain.2009.09.017. Epub 2010 Mar 19. Pain. 2010. PMID: 20303665 Clinical Trial.

3

Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America, and the Middle East.

Hoffman DL, Sadosky A, Alvir J. Hoffman DL, et al. Pain Pract. 2009 Jan-Feb;9(1):35-42. doi: 10.1111/j.1533-2500.2008.00249.x. Epub 2008 Oct 27. Pain Pract. 2009. PMID: 19019046

4

Toward characterization and definition of fibromyalgia severity.

Silverman S, Sadosky A, Evans C, Yeh Y, Alvir JM, Zlateva G. Silverman S, et al. Among authors: alvir jm. BMC Musculoskelet Disord. 2010 Apr 8;11:66. doi: 10.1186/1471-2474-11-66. BMC Musculoskelet Disord. 2010. PMID: 20377879 Free PMC article.

5

Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia.

Sanchez RJ, Uribe C, Li H, Alvir J, Deminski M, Chandran A, Palacio A. Sanchez RJ, et al. Curr Med Res Opin. 2011 Mar;27(3):663-71. doi: 10.1185/03007995.2010.550605. Epub 2011 Jan 18. Curr Med Res Opin. 2011. PMID: 21241205

6

Efficacy of meta-cognitive therapy for adult ADHD.

Solanto MV, Marks DJ, Wasserstein J, Mitchell K, Abikoff H, Alvir JM, Kofman MD. Solanto MV, et al. Among authors: alvir jm. Am J Psychiatry. 2010 Aug;167(8):958-68. doi: 10.1176/appi.ajp.2009.09081123. Epub 2010 Mar 15. Am J Psychiatry. 2010. PMID: 20231319 Free PMC article. Clinical Trial.

7

Latent Class Analysis to Classify Patients with Transthyretin Amyloidosis by Signs and Symptoms.

Alvir J, Stewart M, Conceição I. Alvir J, et al. Neurol Ther. 2015 Jun;4(1):11-24. doi: 10.1007/s40120-015-0028-y. Epub 2015 May 5. Neurol Ther. 2015. PMID: 26847672 Free PMC article.

8

Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).

Mundayat R, Stewart M, Alvir J, Short S, Ong ML, Keohane D, Rill D, Sultan MB. Mundayat R, et al. Neurol Ther. 2018 Jun;7(1):87-101. doi: 10.1007/s40120-018-0097-9. Epub 2018 Apr 9. Neurol Ther. 2018. PMID: 29633228 Free PMC article.

9

Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers.

Stewart M, Shaffer S, Murphy B, Loftus J, Alvir J, Cicchetti M, Lenderking WR. Stewart M, et al. Neurol Ther. 2018 Dec;7(2):349-364. doi: 10.1007/s40120-018-0106-z. Epub 2018 Aug 2. Neurol Ther. 2018. PMID: 30073497 Free PMC article.

10

Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial.

Li B, Alvir J, Stewart M. Li B, et al. Cardiol Ther. 2020 Dec;9(2):535-540. doi: 10.1007/s40119-020-00179-2. Epub 2020 Jun 10. Cardiol Ther. 2020. PMID: 32524297 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters